These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 24789257

  • 21. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E, Hojjat SP, Vitorino R, Carroll TJ, Cantrell CG, Lee L, Taylor MW, Morrow SA, Benhabib H, Aviv RI, Kassner A.
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [Abstract] [Full Text] [Related]

  • 22. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P.
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [Abstract] [Full Text] [Related]

  • 23. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D, Gros C, Badji A, Dupont SM, De Leener B, Maranzano J, Zhuoquiong R, Liu Y, Granberg T, Ouellette R, Stawiarz L, Hillert J, Talbott J, Bannier E, Kerbrat A, Edan G, Labauge P, Callot V, Pelletier J, Audoin B, Rasoanandrianina H, Brisset JC, Valsasina P, Rocca MA, Filippi M, Bakshi R, Tauhid S, Prados F, Yiannakas M, Kearney H, Ciccarelli O, Smith SA, Andrada Treaba C, Mainero C, Lefeuvre J, Reich DS, Nair G, Shepherd TM, Charlson E, Tachibana Y, Hori M, Kamiya K, Chougar L, Narayanan S, Cohen-Adad J.
    Brain; 2019 Mar 01; 142(3):633-646. PubMed ID: 30715195
    [Abstract] [Full Text] [Related]

  • 24. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
    Fisniku LK, Altmann DR, Cercignani M, Tozer DJ, Chard DT, Jackson JS, Miszkiel KA, Schmierer K, Thompson AJ, Miller DH.
    Mult Scler; 2009 Jun 01; 15(6):668-77. PubMed ID: 19435751
    [Abstract] [Full Text] [Related]

  • 25. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug 01; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 26. Resting state networks change in clinically isolated syndrome.
    Roosendaal SD, Schoonheim MM, Hulst HE, Sanz-Arigita EJ, Smith SM, Geurts JJ, Barkhof F.
    Brain; 2010 Jun 01; 133(Pt 6):1612-21. PubMed ID: 20356855
    [Abstract] [Full Text] [Related]

  • 27. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
    Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E.
    J Neurol Sci; 2016 Jul 15; 366():229-233. PubMed ID: 27288812
    [Abstract] [Full Text] [Related]

  • 28. Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.
    Matsushita F, Kida H, Tabei KI, Nakano C, Matsuura K, Ii Y, Sasaki R, Taniguchi A, Narita Y, Maeda M, Satoh M, Tomimoto H.
    Brain Behav; 2018 Mar 15; 8(3):e00934. PubMed ID: 29541544
    [Abstract] [Full Text] [Related]

  • 29. Neuropsychological correlates of cerebellar volumes in multiple sclerosis: an MRI volumetric analysis study.
    Iliadou P, Bakirtzis C, Ioannidis P, Possin K, Zygouris S, Sintila SA, Grigoriadis N, Aretouli E.
    J Integr Neurosci; 2022 Jan 28; 21(1):13. PubMed ID: 35164449
    [Abstract] [Full Text] [Related]

  • 30. Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
    Brownlee WJ, Solanky B, Prados F, Yiannakas M, Da Mota P, Riemer F, Cardoso MJ, Ourselin S, Golay X, Gandini Wheeler-Kingshott C, Ciccarelli O.
    J Neurol Neurosurg Psychiatry; 2019 Jul 28; 90(7):755-760. PubMed ID: 30948625
    [Abstract] [Full Text] [Related]

  • 31. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R, Treaba CA, Granberg T, Herranz E, Barletta V, Mehndiratta A, De Leener B, Tauhid S, Yousuf F, Dupont SM, Klawiter EC, Sloane JA, Bakshi R, Cohen-Adad J, Mainero C.
    Brain; 2020 Oct 01; 143(10):2973-2987. PubMed ID: 32935834
    [Abstract] [Full Text] [Related]

  • 32. Early red nucleus atrophy in relapse-onset multiple sclerosis.
    Margoni M, Poggiali D, Zywicki S, Rubin M, Lazzarotto A, Franciotta S, Anglani MG, Causin F, Rinaldi F, Perini P, Filippi M, Gallo P.
    Hum Brain Mapp; 2021 Jan 01; 42(1):154-160. PubMed ID: 33047810
    [Abstract] [Full Text] [Related]

  • 33. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Haider L, Prados F, Chung K, Goodkin O, Kanber B, Sudre C, Yiannakas M, Samson RS, Mangesius S, Thompson AJ, Gandini Wheeler-Kingshott CAM, Ciccarelli O, Chard DT, Barkhof F.
    Brain; 2021 Jun 22; 144(5):1384-1395. PubMed ID: 33880511
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O, Gouveia A, Batista S, Moura C, Machado E.
    Neuroradiol J; 2015 Jun 22; 28(3):354-8. PubMed ID: 26246109
    [Abstract] [Full Text] [Related]

  • 36. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 22; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M, Lotze M, Langner S, Dressel A.
    J Neurol; 2016 Jun 22; 263(6):1137-45. PubMed ID: 27094570
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.